Related Experiment Videos

Pediatric readmission prevalence and variability across hospitals

Jay G Berry1, Sara L Toomey, Alan M Zaslavsky

  • 1Division of General Pediatrics, Boston Children's Hospital, Harvard Medical School, 300 Longwood Ave, Boston, MA 02115, USA. jay.berry@childrens.harvard.edu

JAMA
|January 24, 2013
PubMed

Insights

Pediatric readmission rates vary significantly across children's hospitals, with high-rate hospitals showing 28.6% higher adjusted 30-day readmissions than low-rate hospitals. These findings highlight opportunities for quality improvement in pediatric care.

Area of Science:

  • Pediatric Healthcare Quality
  • Hospital Readmission Research
  • Health Services Research

Background:

  • Readmission rates serve as a key performance indicator for hospital care quality.
  • Understanding variations in pediatric readmissions is crucial for targeted quality improvement initiatives.

Purpose of the Study:

  • To assess the prevalence of pediatric readmissions.
  • To quantify the variation in 30-day pediatric readmission rates among children's hospitals.

Main Methods:

  • Analysis of 568,845 pediatric admissions across 72 children's hospitals from July 2009 to June 2010.
  • Hierarchical regression models were used to estimate adjusted 30-day readmission rates, controlling for patient age and chronic conditions.
  • Hospitals were categorized as high or low readmission rate based on adjusted rates relative to the mean.

Main Results:

  • The overall unadjusted 30-day readmission rate for hospitalized children was 6.5%.
  • Hospitals with high readmission rates had adjusted rates 28.6% higher than those with low rates (7.2% vs. 5.6%).
  • Significant variability was observed for specific diagnoses, with high-readmission hospitals showing 17.0% to 66.0% higher adjusted rates.

Conclusions:

  • A substantial 6.5% of pediatric patients experienced unplanned 30-day readmissions.
  • Significant disparities in readmission rates exist across different pediatric conditions and healthcare facilities.
  • These findings provide valuable data for hospitals aiming to enhance the quality of pediatric care and reduce readmissions.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Variability: Analysis01:11

Variability: Analysis

Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...